| Literature DB >> 33057408 |
Akua Obeng Forson1, David Nana Adjei1, Michael Olu-Taiwo1, Marjorie Ntiwaa Quarchie1, Harry Richard Asmah2.
Abstract
BACKGROUND: Campylobacter infections in HIV positive patients often present with substantial mortality and morbidity when compared to HIV negative patients. AIM: This study assessed the prevalence of Campylobacter, antibiotic resistance phenotypes and genetic factors, and risk of Campylobacter infection associated with living in close proximity to domestic animals in HIV patients with gastric enteritis at Korle-Bu Teaching Hospital, Accra, Ghana.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33057408 PMCID: PMC7561167 DOI: 10.1371/journal.pone.0240242
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Guidelines for interpreting antimicrobial susceptibility results for Campylobacter spp.
| Zone diameter breakpoint(mm) | |||||
|---|---|---|---|---|---|
| Antibiotic | Disk Content μg | Susceptibility ≥ | Resistance < | Reference | |
| Ampicillin | 10 | 14 | 14 | EUCAST break point for | |
| Ciprofloxacin | 5 | 26 | 26 | EUCAST break point for | |
| Erythromycin | 15 | 24 | 24 | EUCAST break point for | |
| Tetracycline | 30 | 30 | 30 | EUCAST break point for | |
| Gentamicin | 10 | 17 | 14 | EUCAST break point for | |
| Chloramphenicol | 30 | 17 | 17 | EUCAST break point for | |
| Streptomycin | 10 | 15 | 12 | CLSI break point [ | |
Primers used for PCR in this study.
| Primer Sequence (5’-3’) | Amplicon | Annealing | |||
|---|---|---|---|---|---|
| Primer | Forward | Reverse | Sizes (bp) | Temperatures | Reference |
| CJF | 323 | 59°C | [ | ||
| CCF | 126 | 59°C | [ | ||
| CLF | 251 | 59°C | [ | ||
| CUF | 204 | 59°C | [ | ||
| CFF | 435 | 59°C | [ | ||
| 23SF | 650 | 59°C | [ | ||
| 559 | 49°C | [ | |||
| 241 | 49°C | [ | |||
| 372 | 49°C | [ | |||
| 701 | 49°C | [ | |||
| 837 | 49°C | [ | |||
Distribution of ages and Campylobacter coli infections in patients.
| Positive (n = 57, %) | Odds ratio | P-value | ||
| 20–30 | 8 | 5 (8.8) | ||
| 31–40 | 35 | 18 (31.6) | ||
| 41–50 | 30 | 18 (31.6) | 1.583 | 0.0991 |
| 51–60 | 18 | 12 (21.1) | ||
| 61–70 | 4 | 3 (5.3) | ||
| 71–80 | 2 | 1 (1.8) | ||
| Positive (n = 14, %) | Odds ratio | P-value | ||
| 20–30 | 2 | 0 | ||
| 31–40 | 6 | 0 | ||
| 41–50 | 14 | 9(64.3) | 1.589 | 0.3758 |
| 51–60 | 12 | 4(28.6) | ||
| 61–70 | 5 | 1(7.2) | ||
| 71–80 | 4 | 0 | ||
Distribution of ages of patients and contact with domestic animals patients.
| Positive Patients (n = 71) | Negative Patients (n = 69) | |||||||
|---|---|---|---|---|---|---|---|---|
| Domestic Animals | Domestic Animals | |||||||
| Ages | Cats | Dogs | chickens | Goats | Cats | Dogs | chickens | Goats |
| 20–30 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
| 31–40 | 0 | 1 | 12 | 3 | 0 | 1 | 9 | 2 |
| 41–50 | 1 | 2 | 10 | 5 | 0 | 1 | 7 | 3 |
| 51–60 | 0 | 0 | 10 | 0 | 1 | 1 | 6 | 2 |
| 61–70 | 0 | 0 | 3 | 1 | 0 | 0 | 0 | 0 |
| 71–80 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| 1 (1.4) | 3 (4.3) | 22 (31.9) | 8 (11.6) | |||||
Prevalence of phenotypic antibiotic resistance and resistance genes in Campylobacter coli isolates.
| No. of isolates positive for resistance genes | |
|---|---|
| 71 (100) | |
| 1 (1.41) | |
| 49 (69.0) | |
| 51 (71.8) | |
| 5 (7.0) | |
| 71 (100) | |
| 6 (8.4) | |
| 45 (63.4) | |
| 4 (5.6) | |
| 35(49.3) | |
| 20 (28.2) |